BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Mégraud F, Xiao SD, Sugano K, Nyrén O; Lejondal H. pylori-Gastric Cancer Task Force. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100-15. [PMID: 16128957 DOI: 10.1111/j.1572-0241.2005.41688.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Ciccaglione AF, Cellini L, Grossi L, Marzio L. Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pyloriWorld J Gastroenterol 2012; 18(32): 4386-4390 [PMID: 22969203 DOI: 10.3748/wjg.v18.i32.4386] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
2 Mescoli C, Gallo Lopez A, Taxa Rojas L, Jove Oblitas W, Fassan M, Rugge M. Gastritis staging as a clinical priority. Eur J Gastroenterol Hepatol. 2018;30:125-129. [PMID: 29215433 DOI: 10.1097/meg.0000000000001015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P; faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015;64:1353-67. [PMID: 26187502 DOI: 10.1136/gutjnl-2015-309252] [Cited by in Crossref: 741] [Cited by in F6Publishing: 612] [Article Influence: 105.9] [Reference Citation Analysis]
4 Kotynia J, Kordek R, Kozlowska A, Malecka-Panas E. Gastric mucosal proliferative and total tyrosine kinases activities increase in Helicobacter pylori-induced chronic gastritis. Int J Gastrointest Cancer 2005;36:121-30. [PMID: 16720908 DOI: 10.1385/IJGC:36:3:121] [Reference Citation Analysis]
5 Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81. [PMID: 17170018 DOI: 10.1136/gut.2006.101634] [Cited by in Crossref: 1270] [Cited by in F6Publishing: 1146] [Article Influence: 84.7] [Reference Citation Analysis]
6 Malfertheiner P, Fry LC, Mönkemüller K. Can gastric cancer be prevented by Helicobacter pylori eradication? Best Practice & Research Clinical Gastroenterology 2006;20:709-19. [DOI: 10.1016/j.bpg.2006.04.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
7 Malfertheiner P. Helicobacter pylori--a timeless source of lessons and research initiatives. Helicobacter 2007;12 Suppl 2:85-9. [PMID: 17991183 DOI: 10.1111/j.1523-5378.2007.00577.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. [PMID: 17170018 DOI: 10.1036/gut.2006.101634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Kim TH, Han SW. Atrophic Gastritis: Reversible after Treatment? Korean J Helicobacter Up Gastrointest Res 2013;13:25. [DOI: 10.7704/kjhugr.2013.13.1.25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Smith S, Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. Eur J Gastroenterol Hepatol. 2017;29:552-559. [PMID: 28350745 DOI: 10.1097/meg.0000000000000822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. [PMID: 17170018 DOI: 10.1136/gut.2006.101634.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Murray-Stewart T, Sierra JC, Piazuelo MB, Mera RM, Chaturvedi R, Bravo LE, Correa P, Schneider BG, Wilson KT, Casero RA. Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. Oncogene 2016;35:5480-8. [PMID: 27041578 DOI: 10.1038/onc.2016.91] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
13 Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, Wang JX, Zhang L, Zhang Y, Bajbouj M, Zhang LF, Li M, Vieth M, Liu RY, Quante M, Wang LH, Suchanek S, Zhou T, Guan WX, Schmid R, Classen M, You WC. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 2016;65:9-18. [PMID: 25986943 DOI: 10.1136/gutjnl-2015-309197] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 14.8] [Reference Citation Analysis]
14 Martinez-Gomis J, Diouf A, Lakhssassi N, Sixou M. Absence of Helicobacter pylori in the oral cavity of 10 non-dyspeptic subjects demonstrated by real-time polymerase chain reaction. Oral Microbiol Immunol 2006;21:407-10. [PMID: 17064400 DOI: 10.1111/j.1399-302X.2006.00295.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
15 Desai S, Dharavath B, Manavalan S, Rane A, Redhu AK, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam MD, Banerjee A, Prabhash K, Nair S, Dutt A. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 2022;4:zcac006. [PMID: 35252868 DOI: 10.1093/narcan/zcac006] [Reference Citation Analysis]
16 Nyrén O, Blot WJ. Helicobacter pylori Infection: Mainly Foe but Also Friend? JNCI: Journal of the National Cancer Institute 2006;98:1432-4. [DOI: 10.1093/jnci/djj422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
17 Hermann C. Review: variability of host-pathogen interaction. J Endotoxin Res 2007;13:199-218. [PMID: 17956939 DOI: 10.1177/0968051907082605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
18 Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25. [PMID: 17608775 DOI: 10.1111/j.1572-0241.2007.01393.x] [Cited by in Crossref: 805] [Cited by in F6Publishing: 717] [Article Influence: 53.7] [Reference Citation Analysis]
19 Vogelmann R, Amieva MR. The role of bacterial pathogens in cancer. Curr Opin Microbiol 2007;10:76-81. [PMID: 17208515 DOI: 10.1016/j.mib.2006.12.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
20 Trautmann K, Stolte M, Miehlke S. Eradication of H pylori for the prevention of gastric cancer. World J Gastroenterol 2006; 12(32): 5101-5107 [PMID: 16937519 DOI: 10.3748/wjg.v12.i32.5101] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
21 de Korwin J. La gastrite à Helicobacter pylori, une pathologie frontière. La Revue de Médecine Interne 2006;27:S61-3. [DOI: 10.1016/j.revmed.2006.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Selgrad M, Bornschein J, Rokkas T, Malfertheiner P. Clinical aspects of gastric cancer and Helicobacter pylori--screening, prevention, and treatment. Helicobacter. 2010;15 Suppl 1:40-45. [PMID: 21054652 DOI: 10.1111/j.1523-5378.2010.00783.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
23 Kwape L, Ocampo C, Oyekunle A, Mwita J. Vitamin B12 deficiency in patients with diabetes at a specialised diabetes clinic, Botswana. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2021;26:101-5. [DOI: 10.1080/16089677.2021.1927586] [Reference Citation Analysis]
24 Murakami TT, Scranton RA, Brown HE, Harris RB, Chen Z, Musuku S, Oren E. Management of Helicobacter Pylori in the United States: Results from a national survey of gastroenterology physicians. Prev Med 2017;100:216-22. [PMID: 28457713 DOI: 10.1016/j.ypmed.2017.04.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Li ZM, Zhuang X. Application of artificial intelligence in microbiome study promotes precision medicine for gastric cancer. Artif Intell Gastroenterol 2021; 2(4): 105-110 [DOI: 10.35712/aig.v2.i4.105] [Reference Citation Analysis]
26 Malfertheiner P, Link A, Selgrad M. Helicobacter pylori: perspectives and time trends. Nat Rev Gastroenterol Hepatol. 2014;11:628-638. [PMID: 25001975 DOI: 10.1038/nrgastro.2014.99] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 10.3] [Reference Citation Analysis]
27 Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: A systematic review and meta-analysis. World J Gastroenterol 2014; 20(19): 5903-5911 [PMID: 24914352 DOI: 10.3748/wjg.v20.i19.5903] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
28 Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;102:1789-98. [PMID: 17521398 DOI: 10.1111/j.1572-0241.2007.01335.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 6.5] [Reference Citation Analysis]
29 Xu X, Liu Z, Fang M, Yu H, Liang X, Li X, Liu X, Chen C, Jia J. Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases. Exp Biol Med (Maywood). 2012;237:435-441. [PMID: 22442341 DOI: 10.1258/ebm.2011.011199] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
30 Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20:280-322. [PMID: 17428887 DOI: 10.1128/cmr.00033-06] [Cited by in Crossref: 385] [Cited by in F6Publishing: 185] [Article Influence: 25.7] [Reference Citation Analysis]
31 Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132:1272-1276. [PMID: 23180638 DOI: 10.1002/ijc.27965] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
32 Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014;29:520-528. [PMID: 24065381 DOI: 10.1007/s11606-013-2630-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
33 Chandra Babu TM, Rajesh SS, Bhaskar BV, Devi S, Rammohan A, Sivaraman T, Rajendra W. Molecular docking, molecular dynamics simulation, biological evaluation and 2D QSAR analysis of flavonoids from Syzygium alternifolium as potent anti-Helicobacter pylori agents. RSC Adv 2017;7:18277-92. [DOI: 10.1039/c6ra27872h] [Cited by in Crossref: 25] [Article Influence: 5.0] [Reference Citation Analysis]
34 Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136-47. [PMID: 22242613 DOI: 10.3109/00365521.2011.645501] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 8.2] [Reference Citation Analysis]
35 Wang T, Yang X, Li Y, Li L, Liu J, Ji C, Sun Y, Li Y, Zuo X. Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study. Helicobacter. 2019;24:e12569. [PMID: 30848868 DOI: 10.1111/hel.12569] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
36 Zaidi SF, Yamamoto T, Refaat A, Ahmed K, Sakurai H, Saiki I, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter. 2009;14:588-595. [PMID: 19889077 DOI: 10.1111/j.1523-5378.2009.00724.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
37 Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am. 2011;21:613-635. [PMID: 21944414 DOI: 10.1016/j.giec.2011.07.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
38 Wu C, Huang M, Yeh C, Wang J, Cheng T, Lin S. Overexpression of Helicobacter pylori –Associated Urease mRNAs in Human Gastric Cancer. DNA and Cell Biology 2007;26:641-8. [DOI: 10.1089/dna.2007.0599] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
39 Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4(7): 156-169 [PMID: 22844547 DOI: 10.4251/wjgo.v4.i7.156] [Cited by in CrossRef: 256] [Cited by in F6Publishing: 232] [Article Influence: 25.6] [Reference Citation Analysis]
40 Cizginer S, Ordulu Z, Kadayifci A. Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Ther 2014; 5(3): 139-147 [PMID: 25133042 DOI: 10.4292/wjgpt.v5.i3.139] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
41 Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, Oguma K, Okada H, Yamamoto K. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46:318-324. [PMID: 21103997 DOI: 10.1007/s00535-010-0347-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 6.3] [Reference Citation Analysis]
42 Krueger S, Hundertmark T, Kalinski T, Peitz U, Wex T, Malfertheiner P, Naumann M, Roessner A. Helicobacter pylori encoding the pathogenicity island activates matrix metalloproteinase 1 in gastric epithelial cells via JNK and ERK. J Biol Chem. 2006;281:2868-2875. [PMID: 16321971 DOI: 10.1074/jbc.m511053200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
43 Lee YC, Liou JM, Wu MS, Wu CY, Lin JT. Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Therap Adv Gastroenterol. 2008;1:111-120. [PMID: 21180520 DOI: 10.1177/1756283x08094880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther. 2007;25:455-461. [PMID: 17270001 DOI: 10.1111/j.1365-2036.2006.03224.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
45 Otero LL, Ruiz VE, Perez Perez GI. Helicobacter pylori: The balance between a role as colonizer and pathogen. Best Practice & Research Clinical Gastroenterology 2014;28:1017-29. [DOI: 10.1016/j.bpg.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
46 Lian G, Wei C, Wang D, Cui M, Wang Z, Liu X, Li W, Wang L, Wang Q, Zhang DY, Suo J, Ye F. Protein profiling of Helicobacter pylori-associated gastric cancer. Am J Pathol 2014;184:1343-54. [PMID: 24589339 DOI: 10.1016/j.ajpath.2014.01.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
47 Abdulamir AS, Hafidh RR, Bakar FA. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 2010;9:249. [PMID: 20846456 DOI: 10.1186/1476-4598-9-249] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 9.7] [Reference Citation Analysis]
48 Diouf A, Martinez-gomis J, Miquel M, Quesada M, Lario S, Sixou M. Comparaison de quatre paires d’amorces différentes dans la détection d’Helicobacter pylori dans les biopsies gastriques et les prélèvements oraux. Pathologie Biologie 2009;57:30-5. [DOI: 10.1016/j.patbio.2008.07.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin N Am 2008;17:323-40, viii. [PMID: 18375355 DOI: 10.1016/j.soc.2008.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
50 Moayyedi P. The health economics of Helicobacter pylori infection. Best Practice & Research Clinical Gastroenterology 2007;21:347-61. [DOI: 10.1016/j.bpg.2006.11.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
51 Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV, Paul JA, Kao JY. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 2011;60:1479-86. [PMID: 21471567 DOI: 10.1136/gut.2010.220087] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
52 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
53 Lina TT, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Helicobacter pylori elicits B7H3 expression on gastric epithelial cells: Implications in local T cell regulation and subset development during infection. Clin Oncol Res 2019;2. [PMID: 31998864 DOI: 10.31487/j.cor.2019.05.05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Schulz C, Schütte K, Mayerle J, Malfertheiner P. The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond.Therap Adv Gastroenterol. 2019;12:1756284819894062. [PMID: 31897087 DOI: 10.1177/1756284819894062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
55 Ronellenfitsch U, Kyobutungi C, Ott JJ, Paltiel A, Razum O, Schwarzbach M, Winkler V, Becher H. Stomach cancer mortality in two large cohorts of migrants from the Former Soviet Union to Israel and Germany: are there implications for prevention? Eur J Gastroenterol Hepatol. 2009;21:409-416. [PMID: 19242359 DOI: 10.1097/meg.0b013e3283155220] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Mikhailovich V, Gryadunov D, Kolchinsky A, Makarov AA, Zasedatelev A. DNA microarrays in the clinic: infectious diseases. Bioessays 2008;30:673-82. [PMID: 18536036 DOI: 10.1002/bies.20781] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
57 Mantzorou M, Zarros A, Vasios G, Theocharis S, Pavlidou E, Giaginis C. Cranberry: A Promising Natural Source of Potential Nutraceuticals with Anticancer Activity. Anticancer Agents Med Chem 2019;19:1672-86. [PMID: 31272361 DOI: 10.2174/1871520619666190704163301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
58 Pittman ME, Khararjian A, Wood LD, Montgomery EA, Voltaggio L. Prospective identification of Helicobacter pylori in routine gastric biopsies without reflex ancillary stains is cost-efficient for our health care system. Human Pathology 2016;58:90-6. [DOI: 10.1016/j.humpath.2016.07.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Sykes PD, Neoptolemos JP, Costello E, Halloran CM. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Review of Gastroenterology & Hepatology 2014;6:343-56. [DOI: 10.1586/egh.12.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
60 Romano M, Ricci V, Zarrilli R. Mechanisms of Disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemoprevention. Nat Rev Gastroenterol Hepatol 2006;3:622-32. [DOI: 10.1038/ncpgasthep0634] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
61 Pich OQ, Merrell DS. The ferric uptake regulator of Helicobacter pylori: a critical player in the battle for iron and colonization of the stomach. Future Microbiol 2013;8:725-38. [PMID: 23701330 DOI: 10.2217/fmb.13.43] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
62 Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol 2022; 28(12): 1187-1203 [DOI: 10.3748/wjg.v28.i12.1187] [Reference Citation Analysis]
63 Kandulski A, Venerito M, Malfertheiner P. Therapeutic strategies for the treatment of dyspepsia. Expert Opin Pharmacother 2010;11:2517-25. [PMID: 20726822 DOI: 10.1517/14656566.2010.501794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Lee S, Park JM, Park SH, Kim EH, Hahm KB. The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer. J Cancer Prev 2013;18:107-12. [PMID: 25337536 DOI: 10.15430/jcp.2013.18.2.107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 Krueger S, Kuester D, Bernhardt A, Wex T, Roessner A. Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages. J Pathol. 2009;217:581-588. [PMID: 19090485 DOI: 10.1002/path.2485] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
66 Krueger S, Hundertmark T, Kuester D, Kalinski T, Peitz U, Roessner A. Helicobacter pylori alters the distribution of ZO-1 and p120ctn in primary human gastric epithelial cells. Pathol Res Pract. 2007;203:433-444. [PMID: 17509776 DOI: 10.1016/j.prp.2007.04.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
67 Selgrad M, Kandulski A, Malfertheiner P. Helicobacter pylori: diagnosis and treatment. Curr Opin Gastroenterol. 2009;25:549-556. [PMID: 19696666 DOI: 10.1097/mog.0b013e32833159f2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
68 Khuroo MS, Khuroo NS, Khuroo MS. Diffuse duodenal nodular lymphoid hyperplasia: a large cohort of patients etiologically related to Helicobacter pylori infection. BMC Gastroenterol 2011;11:36. [PMID: 21481240 DOI: 10.1186/1471-230X-11-36] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
69 Reynders MB, Deyi VYM, Dahma H, Scheper T, Hanke M, Decolvenaer M, Dediste A. Performance of individual Helicobacter pylori antigens in the immunoblot-based detection of H.pylori infection. FEMS Immunol Med Microbiol 2012;64:352-63. [DOI: 10.1111/j.1574-695x.2011.00920.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
70 Jang BG, Lee BL, Kim WH. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus. PLoS One 2015;10:e0127300. [PMID: 25996368 DOI: 10.1371/journal.pone.0127300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
71 Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15(7): 853-859 [PMID: 19230047 DOI: 10.3748/wjg.15.853] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
72 Peura DA, Crowe SE. Helicobacter pylori. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 833-843.e4. [DOI: 10.1016/b978-1-4160-6189-2.00050-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Johansson J, Håkansson HO, Mellblom L, Kempas A, Kjellén G, Brudin L, Granath F, Johansson KE, Nyrén O. Pancreatic acinar metaplasia in the distal oesophagus and the gastric cardia: prevalence, predictors and relation to GORD. J Gastroenterol 2010;45:291-9. [PMID: 20012917 DOI: 10.1007/s00535-009-0161-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
74 Abdulamir AS, Hafidh RR, Abu Bakar F. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 2011;30:11. [PMID: 21247505 DOI: 10.1186/1756-9966-30-11] [Cited by in Crossref: 155] [Cited by in F6Publishing: 120] [Article Influence: 14.1] [Reference Citation Analysis]
75 Jung YS, Lee SH, Park CS, Oh MJ, Kim KO, Jang BI, Jeon SW, Jung MK, Park KS, Kim ES, Cho KB, Jung JT, Kwon JG, Kim EY, Kim WJ, Yang CH. Trends in the Eradication Rates of Helicobacter pylori Infection in Daegu and Gyeongsangbuk-do, Korea: Multicenter Study over 13 Years. Korean J Gastroenterol 2014;63:82. [DOI: 10.4166/kjg.2014.63.2.82] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
76 Hattar K, Savai R, Subtil FS, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B, Dahlem G, Fink L, Schermuly RT, Banat GA, Sibelius U, Grimminger F, Vollmer E, Seeger W, Grandel U. Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation. Cancer Immunol Immunother 2013;62:309-20. [PMID: 22923191 DOI: 10.1007/s00262-012-1341-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
77 Caselli M, Zullo A, Maconi G, Parente F, Alvisi V, Casetti T, Sorrentino D, Gasbarrini G. “Cervia II Working Group Report 2006”: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis. 2007;39:782-789. [PMID: 17606419 DOI: 10.1016/j.dld.2007.05.016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 4.5] [Reference Citation Analysis]
78 Zhao S, Fu YM, Zhao B, Liu LX. Expression of P53 and C-erbB-2 and their significances in chronic atrophic gastritis. Shijie Huaren Xiaohua Zazhi 2006; 14(30): 2943-2947 [DOI: 10.11569/wcjd.v14.i30.2943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55:3124-3131. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
80 Rojas-Rengifo DF, Alvarez-Silva MC, Ulloa-Guerrero CP, Nuñez-Velez VL, Del Pilar Delgado M, Aguilera SM, Castro H, Jaramillo CA, Fernando González Barrios A. Intramolecular energies of the cytotoxic protein CagA of Helicobacter pylori as a possible descriptor of strains' pathogenicity level. Comput Biol Chem 2018;76:17-22. [PMID: 29864542 DOI: 10.1016/j.compbiolchem.2018.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol 2006;101:211. [PMID: 16454817 DOI: 10.1111/j.1572-0241.2006.00388.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
82 Pappas E, Schaich KM. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 2009;49:741-81. [PMID: 20443158 DOI: 10.1080/10408390802145377] [Cited by in Crossref: 166] [Cited by in F6Publishing: 146] [Article Influence: 13.8] [Reference Citation Analysis]
83 Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol. 2010;105:65-73. [PMID: 19755966 DOI: 10.1038/ajg.2009.508] [Cited by in Crossref: 133] [Cited by in F6Publishing: 122] [Article Influence: 10.2] [Reference Citation Analysis]
84 Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009;124:157-166. [PMID: 18823009 DOI: 10.1002/ijc.23864] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
85 Sugano K. Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. J Gastroenterol 2007;42:1-2. [DOI: 10.1007/s00535-006-1941-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
86 Nuding S, Gersemann M, Hosaka Y, Konietzny S, Schaefer C, Beisner J, Schroeder BO, Ostaff MJ, Saigenji K, Ott G, Schaller M, Stange EF, Wehkamp J. Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance. PLoS One 2013;8:e73867. [PMID: 24040100 DOI: 10.1371/journal.pone.0073867] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
87 Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pyloriWorld J Gastroenterol 2014; 20(19): 5594-5609 [PMID: 24914319 DOI: 10.3748/wjg.v20.i19.5594] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
88 Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:281-297. [PMID: 17382277 DOI: 10.1016/j.bpg.2007.02.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
89 Cárdenas PA, Garcés D, Prado-Vivar B, Flores N, Fornasini M, Cohen H, Salvador I, Cargua O, Baldeón ME. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. Eur J Clin Microbiol Infect Dis 2020;39:1365-72. [PMID: 32125555 DOI: 10.1007/s10096-020-03854-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
90 Jankowski JA, Hawk ET. A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer. Nat Clin Pract Gastroenterol Hepatol 2006;3:101-11. [PMID: 16456576 DOI: 10.1038/ncpgasthep0412] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
91 Becker JC, Domschke W, Pohle T. [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?]. Internist (Berl) 2006;47:1229-30, 1232-4, 1236-8. [PMID: 17075707 DOI: 10.1007/s00108-006-1731-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Ciccaglione AF, Cellini L, Grossi L, Manzoli L, Marzio L. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study. Helicobacter. 2015;20:390-396. [PMID: 25801708 DOI: 10.1111/hel.12209] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
93 Selgrad M, Kandulski A, Malfertheiner P. Dyspepsia and Helicobacter pylori. Dig Dis. 2008;26:210-214. [PMID: 18463437 DOI: 10.1159/000121348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
94 Sisto F, Scaltrito MM, Masia C, Bonomi A, Coccè V, Marano G, Haynes RK, Miani A, Farronato G, Taramelli D. In vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori. International Journal of Antimicrobial Agents 2016;48:101-5. [DOI: 10.1016/j.ijantimicag.2016.03.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
95 Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol. 2007;42 Suppl 17:21-27. [PMID: 17238021 DOI: 10.1007/s00535-006-1924-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
96 Stroh C, Hohmann U, Urban H, Manger T. Gastric Cancer After Laparoscopic Adjustable Gastric Banding. OBES SURG 2008;18:1200-2. [DOI: 10.1007/s11695-008-9473-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
97 De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer: REVIEW: H. PYLORI ERADICATION FOR GASTRIC CANCER PREVENTION. Alimentary Pharmacology & Therapeutics 2007;26:25-35. [DOI: 10.1111/j.1365-2036.2007.03475.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
98 Ciccaglione AF, Cellini L, Marzio L. Pylera® plus ranitidine vs Pylera® plus esomeprazole in first‐line treatment of Helicobacter pylori infection: Two pilot studies. Helicobacter 2019;24. [DOI: 10.1111/hel.12606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
99 Whiteside SA, Mohiuddin MM, Shlimon S, Chahal J, MacPherson CW, Jass J, Tompkins TA, Creuzenet C. In Vitro Framework to Assess the Anti-Helicobacter pylori Potential of Lactic Acid Bacteria Secretions as Alternatives to Antibiotics. Int J Mol Sci 2021;22:5650. [PMID: 34073352 DOI: 10.3390/ijms22115650] [Reference Citation Analysis]
100 Liu XM, Xu CX, Zhang LF, Huang LH, Hu TZ, Li R, Xia XJ, Xu LY, Luo L, Jiang XX, Li M. PBX1 attributes as a determinant of connexin 32 downregulation in Helicobacter pylori-related gastric carcinogenesis. World J Gastroenterol 2017; 23(29): 5345-5355 [PMID: 28839434 DOI: 10.3748/wjg.v23.i29.5345] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol 2010; 16(43): 5395-5404 [PMID: 21086555 DOI: 10.3748/wjg.v16.i43.5395] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
102 Gisbert JP, Calvet X, Bermejo F, Boixeda D, Bory F, Bujanda L, Castro-Fernández M, Dominguez-Muñoz E, Elizalde JI, Forné M, Gené E, Gomollón F, Lanas Á, Martín de Argila C, McNicholl AG, Mearin F, Molina-Infante J, Montoro M, Pajares JM, Pérez-Aisa A, Pérez-Trallero E, Sánchez-Delgado J. [III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol 2013;36:340-74. [PMID: 23601856 DOI: 10.1016/j.gastrohep.2013.01.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
103 Malfertheiner P, Bornschein J, Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J Dig Dis. 2010;11:2-11. [PMID: 20132425 DOI: 10.1111/j.1751-2980.2009.00408.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
104 Triantafyllou K, Papadopoulos V, Emanouil T, Gkolfakis P, Damaskou V, Tziatzios G, Panayiotides IG, Vafiadis I, Ladas SD. Eradication of Helicobacter pylori Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium. Clin Med Insights Gastroenterol 2016;9:73-8. [PMID: 27891056 DOI: 10.4137/CGast.S38330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Capurso G, Carnuccio A, Lahner E, Panzuto F, Baccini F, Delle Fave G, Annibale B. Corpus-predominant gastritis as a risk factor for false-negative 13C-urea breath test results. Aliment Pharmacol Ther. 2006;24:1453-1460. [PMID: 17032284 DOI: 10.1111/j.1365-2036.2006.03143.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
106 Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 Kim JS, Kim BW, Hong SJ, Kim JI, Shim KN, Kim JH, Baik GH, Kim SW, Song HJ, Kim JH. Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. Gut Liver. 2016; Apr 28. [Epub ahead of print]. [PMID: 27114421 DOI: 10.5009/gnl15470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
108 Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel) 2019;11:E593. [PMID: 31035365 DOI: 10.3390/cancers11050593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
109 Goswami S, Bhakuni RS, Chinniah A, Pal A, Kar SK, Das PK. Anti-Helicobacter pylori potential of artemisinin and its derivatives. Antimicrob Agents Chemother. 2012;56:4594-4607. [PMID: 22687518 DOI: 10.1128/aac.00407-12] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
110 Ciccaglione AF, Tavani R, Grossi L, Cellini L, Manzoli L, Marzio L. Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies. Helicobacter 2016;21:375-81. [PMID: 26807668 DOI: 10.1111/hel.12296] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
111 Smith SM, O’Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol 2014; 20(29): 9912-9921 [PMID: 25110421 DOI: 10.3748/wjg.v20.i29.9912] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
112 Dietz J, Ulbrich-kulcynski JM, Souto KEP, Meinhardt NG. Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients. Arq Gastroenterol 2012;49:52-5. [DOI: 10.1590/s0004-28032012000100009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
113 Leja M, Dumitrascu DL. Should we screen for Helicobacter pylori to prevent gastric cancer? Dig Dis 2007;25:218-21. [PMID: 17827943 DOI: 10.1159/000103888] [Reference Citation Analysis]
114 Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83:253-260. [PMID: 21282951 DOI: 10.1159/000280318] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
115 Pelz C, Steininger S, Weiss C, Coscia F, Vogelmann R. A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology. J Biol Chem 2011;286:8999-9008. [PMID: 21212271 DOI: 10.1074/jbc.M110.166504] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
116 Tong W, Ye F, He L, Cui L, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J. Serum biomarker panels for diagnosis of gastric cancer. Onco Targets Ther. 2016;9:2455-2463. [PMID: 27217769 DOI: 10.2147/ott.s86139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
117 Luther J, Chey WD, Saad RJ. A clinician’s guide to salvage therapy for persistent Helicobacter pylori infection. Hosp Pract (1995). 2011;39:133-140. [PMID: 21441768 DOI: 10.3810/hp.2011.02.383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
118 Ulloa-Guerrero CP, Delgado MDP, Jaramillo CA. Structural Analysis of Variability and Interaction of the N-terminal of the Oncogenic Effector CagA of Helicobacter pylori with Phosphatidylserine. Int J Mol Sci 2018;19:E3273. [PMID: 30360352 DOI: 10.3390/ijms19103273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Starzyñska T, Malfertheiner P. Helicobacter and digestive malignancies. Helicobacter 2006;11 Suppl 1:32-5. [PMID: 16925609 DOI: 10.1111/j.1478-405X.2006.00431.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
120 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
121 Ogura K, Mitsuno Y, Maeda S, Hirata Y, Yanai A, Shibata W, Ohmae T, Yoshida H, Kawabe T, Omata M. Efficacy and Safety of Faropenem in Eradication Therapy of Helicobacter pylori: Faropenem against Helicobacter pylori. Helicobacter 2007;12:618-22. [DOI: 10.1111/j.1523-5378.2007.00551.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
122 Zhao R, Liu Z, Xu W, Song L, Ren H, Ou Y, Liu Y, Wang S. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism. Cancer Med 2020;9:2551-63. [PMID: 32017451 DOI: 10.1002/cam4.2892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
123 Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther. 2007;25:133-141. [PMID: 17229238 DOI: 10.1111/j.1365-2036.2006.03183.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
124 Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M; Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392-397. [PMID: 18675689 DOI: 10.1016/s0140-6736(08)61159-9] [Cited by in Crossref: 769] [Cited by in F6Publishing: 364] [Article Influence: 54.9] [Reference Citation Analysis]
125 Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis. 2008;40:619-626. [PMID: 18396114 DOI: 10.1016/j.dld.2008.02.026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
126 Ishida Y, Goto Y, Kondo T, Kurata M, Nishio K, Kawai S, Osafune T, Naito M, Hamajima N. Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A. Int J Med Sci. 2006;3:135-140. [PMID: 17003844 DOI: 10.7150/ijms.3.135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
127 Pushalkar S, Mane SP, Ji X, Li Y, Evans C, Crasta OR, Morse D, Meagher R, Singh A, Saxena D. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 2011;61:269-77. [PMID: 21205002 DOI: 10.1111/j.1574-695X.2010.00773.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
128 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
129 Fukushige S, Horii A. Technological advances in epigenomics lead to a better understanding of inflammatory diseases, decitabine and H3K27me3. Epigenomics 2015;7:133-6. [PMID: 25942529 DOI: 10.2217/epi.14.90] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017;15:1833-1843. [PMID: 28532700 DOI: 10.1016/j.cgh.2017.05.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 18.6] [Reference Citation Analysis]
131 Lam VWT, Trinh LK, Wilson RB. HELICOBACTER PYLORI INFECTION AND TREATMENT OUTCOME IN AN URBAN AUSTRALIAN POPULATION. ANZ J Surg 2006;76:710-4. [DOI: 10.1111/j.1445-2197.2006.03836.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
132 Khoshnegah J, Jamshidi S, Mohammadi M, Sasani F. The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection. J Feline Med Surg 2011;13:88-93. [PMID: 21144784 DOI: 10.1016/j.jfms.2010.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
133 Hatakeyama M, Brzozowski T. Pathogenesis of Helicobacter pylori Infection. Helicobacter 2006;11:14-20. [DOI: 10.1111/j.1478-405x.2006.00424.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
134 Selgrad M, Malfertheiner P, Fini L, Goel A, Boland CR, Ricciardiello L. The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol 2008;216:378-88. [PMID: 18338378 DOI: 10.1002/jcp.21427] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
135 Khan AA, Shrivastava A. Bacterial infections associated with cancer: possible implication in etiology with special reference to lateral gene transfer. Cancer Metastasis Rev 2010;29:331-7. [DOI: 10.1007/s10555-010-9217-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]